News
TNXP ▲ +1.3% - Tonix Pharmaceuticals Holding Corp.
TNXP ▲ +1.3% - Tonix Pharmaceuticals Holding Corp.
$TNXP - Tonix Pharmaceuticals Presented an Analysis of Phase 3 Data Demonstrating TONMYA® Improved Physical Symptoms and Functional Ability of Patients with Fibromyalgia at the IASP 2026 World Congress on Pain
27-OCT-2026 07:00 AM ET
Share this post
More filings for $TNXP
TNXP ▲ +4.8% - Tonix Pharmaceuticals Holding Corp.Oct 26, 2026TNXP ▲ +0.3% - Tonix Pharmaceuticals Holding Corp.Oct 19, 2026TNXP ▲ +3.5% - Tonix Pharmaceuticals Holding Corp.Sep 22, 2026TNXP ▼ -0.9% - Tonix Pharmaceuticals Holding Corp.Sep 8, 2026TNXP - Tonix Pharmaceuticals Holding Corp. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026TNXP - Tonix Pharmaceuticals Holding Corp. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026
View full $TNXP filing history →💬 Comments
Loading comments…
Leave a comment